Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MUCO-OS: Monocytes and Bone Loss in Cystic Fibrosis
NCT03492567Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Apr 2018
- Primary completion
- Jul 2018
- Countries
- 1
01
Overview
Open-label, single-arm trial in cystic fibrosis (CF) and osteoporosis, sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Phenotype of CD14 monocytes and osteoclasts at 1 day. Started Apr 2018; status: completed.
02
Conditions
cystic fibrosis (CF)osteoporosis
Beyond the preview
Go deeper on NCT03492567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03492567.